Skip to main content
Fig. 3 | Implementation Science Communications

Fig. 3

From: Effectiveness of confidential reports to physicians on their prescribing of antipsychotic medications in nursing homes

Fig. 3

Adjusted antipsychotic prescribing at each time period, by exposure group. Adjusted for nursing home variables (number of beds, urban vs. rural location, private vs. public institution), physician variables (sex, age, years practicing, Canadian vs. foreign graduate, number of nursing home residents, number of nursing home institutions practicing, percent of billings in nursing homes), and resident characteristics (sex, age, time in nursing home, Charlson comorbidity scale, diabetes, hypertension, arteriosclerotic heart disease, heart failure, peripheral vascular disease, deep vein thrombosis, cardiac dysrhythmia, Alzheimer’s, dementia, cancer, obstructive airway disease, depression, arthritis, Parkinson’s disease, activities of daily living scale, pain score, depression rating scale, likelihood of falls scale, aggressive behavior scale, frailty index, emergency department visits in past year, inpatient hospitalizations in past year, any phychiatric consult in past year, any geriatric consult in past year, any benzodiazepine use)

Back to article page